Cingulate Sets Sights On $18bn ADHD Market With Precision Timed-Release Approach
Executive Summary
Emerging Company Profile: The US firm’s lead candidate contains a gold standard ADHD simulant packaged in a compressed tablet that releases the ingredient at timed intervals to address symptoms for up to 16 hours.